Back to Startups

Kiin Bio

About Kiin Bio

Kiin Bio is an AI-powered drug discovery platform that develops virtual scientists to accelerate the drug discovery process. The platform leverages advanced artificial intelligence to streamline research and development in the pharmaceutical industry.

Business Information
Target Customers
pharmaceutical companies biotech firms research institutions
Industry Categories
Bioscience & Disease AI, ML, Gen AI Software
Business Model
Revenue Model SaaS
Pricing Strategy Subscription-based
Sales Channels direct sales, partnerships with research institutions
Funding Timeline
Round Date Amount Investors
Pre-Seed Jun 27, 2025 $2.2M b2venture, U.S.-based angel investors
Pre-Seed Jun 09, 2025 $1.9M Unknown
Founders

No founder information available.

Investors
Recent Mentions
IndianVCA
IVCA @IndianVCA
Jun 09, 2025

London’s Kiin Bio gets €1.9 million in pre-seed round to launch its drug discovery platform https://t.co/Ubz8U3ka0g https://t.co/FY7TwCthRo

SynBioBeta
SynBioBeta @SynBioBeta
Jun 27, 2025

Kiin Bio Secures $2.2M Pre-Seed Funding to Revolutionize Drug Discovery with AI. Backed by b2venture and several angel investors, has raised $2.2 million to develop its Virtual Scientist Platform, KiinOS, which aims to streamline and automate the drug discovery process. The https://t.co/bf91XPGluW